Brought to you by 
Lin Bioscience gets dry AMD candidate from Columbia University
30 Jan 2017
Executive Summary
Lin Bioscience Inc. received exclusive worldwide rights from Columbia University to intellectual property and a program aimed at atrophic dry age-related macular degeneration.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lin Bioscience gets dry AMD candidate from Columbia University
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice